Profil
Andrew Allars is currently the Chairman of Azellon Ltd. and the Managing Partner of Anauel LLP since 2003.
He was previously the Chief Executive Officer of Wyvern Asset Management Ltd. and a Director at Prelude Ventures Ltd. from 1990 to 2003.
He was also a Director at KWS BioTest Ltd. from 2012 to 2019.
Allars holds an MBA from Cranfield University and an undergraduate degree from Southampton Business School.
Postes actifs de Andrew Allars
| Sociétés | Poste | Début |
|---|---|---|
Anauel LLP | Corporate Officer/Principal | 01/01/2003 |
Anciens postes connus de Andrew Allars
| Sociétés | Poste | Fin |
|---|---|---|
KWS BioTest Ltd.
KWS BioTest Ltd. Pharmaceuticals: MajorHealth Technology Provides preclinical pharmacology and drug development for human diseases | Corporate Officer/Principal | 01/01/2019 |
Prelude Ventures Ltd.
Prelude Ventures Ltd. Investment ManagersFinance Provides investment services | Corporate Officer/Principal | 01/01/2003 |
Azellon Ltd.
Azellon Ltd. Miscellaneous Commercial ServicesCommercial Services Develops stem cell therapy for the repair of avascular meniscal tears | Président | - |
Wyvern Asset Management Ltd.
Wyvern Asset Management Ltd. Investment ManagersFinance Wyvern Asset Management invests in private companies located in the United Kingdom. The firm focuses on the technology sector. It participates in seed, early, and growth transactions. | Directeur Général | - |
Formation de Andrew Allars
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Cranfield University
Cranfield University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prelude Ventures Ltd.
Prelude Ventures Ltd. Investment ManagersFinance Provides investment services | Finance |
Wyvern Asset Management Ltd.
Wyvern Asset Management Ltd. Investment ManagersFinance Wyvern Asset Management invests in private companies located in the United Kingdom. The firm focuses on the technology sector. It participates in seed, early, and growth transactions. | Finance |
KWS BioTest Ltd.
KWS BioTest Ltd. Pharmaceuticals: MajorHealth Technology Provides preclinical pharmacology and drug development for human diseases | Health Technology |
Azellon Ltd.
Azellon Ltd. Miscellaneous Commercial ServicesCommercial Services Develops stem cell therapy for the repair of avascular meniscal tears | Commercial Services |
Southampton Business School
Southampton Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anauel LLP |
















